Please ensure Javascript is enabled for purposes of website accessibility

Aurora Cannabis Spinoff Cancels Merger With Hemp Company

By Eric Volkman – Updated Feb 21, 2020 at 10:16AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Australis Capital won't be combining with Folium Biosciences after all.

Australis Capital, an investment company that was spun off in 2018 from cannabis industry major Aurora Cannabis (ACB 7.26%), has put the kibosh on a planned business tie-up. Australis announced this week that it has cancelled its previously announced merger with hemp products producer Folium Biosciences.

The company said in a press release that it "recently discovered new relevant information with regard to Folium and, on that basis, [Australis] has decided to not proceed with the merger." It did not elaborate.

Hemp oil.

Image source: Getty Images.

The Australis-Folium deal was announced last December, and it was to take the form of a reverse merger. Under its terms, the two companies would exchange shares (in the case of Australis) and membership units (Folium) to create a new entity. This was to inherit the name Folium Biosciences, with the acquired party holding an estimated 89% of shares in the combination.

At the time, Australis pledged that it would provide details of Folium's financials.

Hemp is seen by numerous analysts and investors to be a good business opportunity in the U.S. The plant produces minimal amounts of Delta-9 tetrahydrocannabinol -- THC, the compound that gets a user high -- compared to its relative, cannabis. However, it produces far higher levels of cannabidiol (CBD), which is purported to have medicinal properties. Hemp-derived products were legalized in the U.S. with the passage of the 2018 Farm Bill.

Australis was created by Canada-based marijuana vertical Aurora to take advantage of cannabis industry investment opportunities in the U.S. As marijuana remains illegal at the federal level in this country, however, Australis stock -- like that of Aurora Cannabis -- is listed in Canada, even though the company is headquartered in Las Vegas.

On Thursday, Aurora shares closed down by nearly 2%. 


Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Inc. Stock Quote
Aurora Cannabis Inc.
$1.33 (7.26%) $0.09

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.